Moneycontrol.com |
Biocon Files IPO Prospectus for R&D Arm Syngene
NDTV Mumbai: Biotech firm Biocon has filed a prospectus for the initial public offering of its $600 million research and development arm, Syngene, it said on Thursday. The company plans to sell 22 million shares, including an overallotment, it said in a statement, ... Biocon gains as arm Syngene files for IPO See more upside for Biocon post Syngene listing: Phillipcap Biocon files Prospectus for Syngene IPO |
from Top Stories - Google News http://ift.tt/1DQKaeE
via IFTTT
No comments:
Post a Comment